Nordic M&A’s healthcare unit is lead by Anne Sofie Astrup
She is supported by our senior advisor Jan Leschly and our strong scientific board of leading international experts within 5 major medical fields
The Nordic healthcare market is expanding and has grown to more than 1,000 DKK bn
With our strong scientific board and the surrounding network of our team we cover all fields within healthcare and life sciences
Team lead Fie Astrup
Director, Dr. Med, MBA
Fie is a medical doctor, and holds a Doctoral of Medical sciences degree based on clinical research within diabetes and cardiovascular complications. She is trained as a cardiovascular surgeon from Rigshospitalet in Denmark. Recently Fie finished an MBA from Copenhagen Business School.
Jan Leschly is well known for his career within the pharmaceutical industry. Jan was Chief Executive of SmithKline Beecham PLC (“SB”) from 1994 to 2000. Before joining SB, Jan served as President and COO in Squibb Corporation and before that he was President for Novo’s Pharmaceuticals Division. In 2000 Jan founded Care Capital and has since then been functioning as managing partner. Jan sits on the Board of Directors of APM Holding and the APM – Maersk Group. Before his glorious business career, Jan Leschly made his name in professional tennis, achieving the rank of 10th in the world in 1967.
Exclusive financial advisor to DMDD on the sale to Synlab International GmbH backed by Novo Holdings
Exclusive financial advisor to
Gjensidige on the acquisition
of Mølholm Forsikring
Exclusive financial advisor to Daintel on the sale to Cambio Healthcare Systems
Financial advisor to Københavns
Dyrehospital on the sale to